News
The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
November 06, 2006
News
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.
November 06, 2006News
Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...
November 05, 2006Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...
November 05, 2006News
Hospitals and other medical facilities across the state of Washington will receive $1 million in grant money allocated ...
November 05, 2006News
A dedicated interventional cardiology track is slated during the 2006 Scientific Sessions of the AHA in Chicago that ...
November 05, 2006Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
The FDA has approved NitroMist (Nitroglycerin Lingual Aerosol) for acute relief of an attack or acute prophylaxis of ...
November 05, 2006News
Washington University surgeons at Barnes-Jewish Hospital, St. Louis, began training at UMC in Tucson on Nov. 2 to become ...
November 05, 2006News
A new alternative to invasive, painful biopsies for determining heart transplant rejection is both available and ...
November 02, 2006Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
November 2006 - Physicians at UT Southwestern Medical Center are part of a multinational clinical trial evaluating the Optimizer System, a unique implantable device designed to treat a larger number of patients with heart failure. UT Southwestern is one of the top enrolling centers of the 50 sites in the U.S.
November 02, 2006News
NewYork-Presbyterian Hospital now offers a new alternative therapy for heart failure patients at risk for sudden cardiac ...
November 02, 2006News
Boston Scientific has launched new software enabling its Left Ventricular (LV) Offset feature in the CONTAK RENEWAL ...
November 02, 2006Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
Well-known cardiologist Eric Topol has been appointed by Scripps Health in San Diego, CA, to lead a new institute to ...
November 02, 2006News
A new cooling pad enters the healthcare market, joining a growing number of cooling systems used to induce hypothermia ...
November 02, 2006News
A large California-based study has shown that patients with heart failure who start taking statins, compared with those who don't, will live longer and have a lower hospitalization risk regardless of cholesterol levels, presence or absence of coronary disease, and other CV drug therapies, “Heartwire” reported this week.
November 01, 2006© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now